ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Hematology Oncology

Top Hematology Oncology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NANDA BISWAS M.D.

Hematology Oncology

15,345

$1.91M

764
536 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$125
Average prescription price

Avg: $486

SAMUEL KUO M.D.

Hematology Oncology

12,459

$717K

413
326 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

33%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $486

SUNG RYOO MD

Hematology Oncology

11,566

$602K

418
330 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $486

SHAN KAUR M.D.

Hematology Oncology

6,893

$339K

309
281 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $486

KALPATHY VENKATESAN MD

Hematology Oncology

6,538

$480K

352
293 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $486

THOMAS WARR MD

Hematology Oncology

6,139

$332K

391
343 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $486

DAVID CHENG M.D

Hematology Oncology

4,508

$1.13M

420
383 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 22%

$251
Average prescription price

Avg: $486

EDUARDO LIM MD

Hematology Oncology

4,488

$2.16M

370
306 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$482
Average prescription price

Avg: $486

CHARNG CHONG M.D.

Hematology Oncology

4,401

$294K

197
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $486

RAYMOND HEUNG M.D.

Hematology Oncology

4,286

$926K

225
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 22%

$216
Average prescription price

Avg: $486

SANJAY GANPULE M.D.

Hematology Oncology

4,227

$261K

530
315 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $486

NORMA MAALA SARAO M.D.

Hematology Oncology

4,126

$199K

247
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $486

WILLIAM CHUA M.D.

Hematology Oncology

3,796

$598K

185
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 22%

$158
Average prescription price

Avg: $486

V. REDDY AVULA MD

Hematology Oncology

3,654

$402K

174
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$110
Average prescription price

Avg: $486

PETER DECK MD

Hematology Oncology

3,565

$359K

366
338 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $486

THOMAS ROSCHAK MD

Hematology Oncology

3,494

$434K

235
216 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$124
Average prescription price

Avg: $486

KARO ARZOO M.D.

Hematology Oncology

3,412

$1.13M

262
217 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$331
Average prescription price

Avg: $486

GABOR KOVACS M.D.

Hematology Oncology

3,255

$300K

207
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $486

RAUL MENA M.D.

Hematology Oncology

3,221

$930K

247
216 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$289
Average prescription price

Avg: $486

FREDERICK RUNDALL MD

Hematology Oncology

3,130

$420K

177
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

27%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$134
Average prescription price

Avg: $486

YOURAM NASSIR MD

Hematology Oncology

3,106

$911K

260
186 are 65+

23%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$293
Average prescription price

Avg: $486

CHAINARONG LIMVARAPUSS MD

Hematology Oncology

3,079

$1.12M

214
154 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$363
Average prescription price

Avg: $486

JEROME RUBIN M.D.

Hematology Oncology

2,832

$398K

231
210 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$141
Average prescription price

Avg: $486

WILLIAM MCINTYRE, JR. M.D.

Hematology Oncology

2,745

$114K

100
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $486

VERA KLEYNBERG M.D.

Hematology Oncology

2,709

$277K

112
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$102
Average prescription price

Avg: $486

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank